GLP-1 receptor agonists’ impact on cardio-renal outcomes and mortality in T2D with acute kidney disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
GLP-1 receptor agonists’ impact on cardio-renal outcomes and mortality in T2D with acute kidney disease ; volume:15 ; number:1 ; day:13 ; month:7 ; year:2024 ; pages:1-10 ; date:12.2024
Nature Communications ; 15, Heft 1 (13.7.2024), 1-10, 12.2024
- Creator
-
Pan, Heng-Chih
Chen, Jui-Yi
Chen, Hsing-Yu
Yeh, Fang-Yu
Sun, Chiao-Yin
Huang, Thomas Tao-Min
Wu, Vin-Cent
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-024-50199-y
- URN
-
urn:nbn:de:101:1-2410020932041.365349727745
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pan, Heng-Chih
- Chen, Jui-Yi
- Chen, Hsing-Yu
- Yeh, Fang-Yu
- Sun, Chiao-Yin
- Huang, Thomas Tao-Min
- Wu, Vin-Cent
- SpringerLink (Online service)
Other Objects (12)
Adolescent type 1 Diabetes cardio-renal Intervention Trial (AdDIT)
Detrimental role of humoral signalling in cardio-renal cross-talk
A multisystem, cardio-renal investigation of post-COVID-19 illness
Cardio-renal cachexia syndromes (CRCS): pathophysiological foundations of a vicious pathological circle
Skin autofluorescence predicts cardio-renal outcome in type 1 diabetes: a longitudinal study
Could Repeated Cardio-Renal Injury Trigger Late Cardiovascular Sequelae in Extreme Endurance Athletes?
Combination Treatment of SGLT2 Inhibitors and GLP-1 Receptor Agonists: Symbiotic Effects on Metabolism and Cardiorenal Risk
Biomarkers of cardio-renal damage in chronic kidney disease: one size cannot fit all
Associations of urinary polymeric immunoglobulin receptor peptides in the context of cardio-renal syndrome
Association of cardio-renal biomarkers and mortality in the U.S.: a prospective cohort study
Cardiorenal Protection: Potential of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes
GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs
Adolescent type 1 Diabetes cardio-renal Intervention Trial (AdDIT)
Detrimental role of humoral signalling in cardio-renal cross-talk
A multisystem, cardio-renal investigation of post-COVID-19 illness
Cardio-renal cachexia syndromes (CRCS): pathophysiological foundations of a vicious pathological circle
Skin autofluorescence predicts cardio-renal outcome in type 1 diabetes: a longitudinal study
Could Repeated Cardio-Renal Injury Trigger Late Cardiovascular Sequelae in Extreme Endurance Athletes?
Combination Treatment of SGLT2 Inhibitors and GLP-1 Receptor Agonists: Symbiotic Effects on Metabolism and Cardiorenal Risk
Biomarkers of cardio-renal damage in chronic kidney disease: one size cannot fit all
Associations of urinary polymeric immunoglobulin receptor peptides in the context of cardio-renal syndrome
Association of cardio-renal biomarkers and mortality in the U.S.: a prospective cohort study
Cardiorenal Protection: Potential of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes
GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs
Adolescent type 1 Diabetes cardio-renal Intervention Trial (AdDIT)
Detrimental role of humoral signalling in cardio-renal cross-talk
A multisystem, cardio-renal investigation of post-COVID-19 illness
Cardio-renal cachexia syndromes (CRCS): pathophysiological foundations of a vicious pathological circle
Skin autofluorescence predicts cardio-renal outcome in type 1 diabetes: a longitudinal study
Could Repeated Cardio-Renal Injury Trigger Late Cardiovascular Sequelae in Extreme Endurance Athletes?
Combination Treatment of SGLT2 Inhibitors and GLP-1 Receptor Agonists: Symbiotic Effects on Metabolism and Cardiorenal Risk
Biomarkers of cardio-renal damage in chronic kidney disease: one size cannot fit all
Associations of urinary polymeric immunoglobulin receptor peptides in the context of cardio-renal syndrome
Association of cardio-renal biomarkers and mortality in the U.S.: a prospective cohort study
Cardiorenal Protection: Potential of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes